K Number
K971155
Device Name
MEMOREG
Date Cleared
1997-05-22

(55 days)

Product Code
Regulation Number
872.3660
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
MEMOREG is indicated for bite registration in all standard situations with a stable occlusion.
Device Description
Not Found
More Information

Not Found

Not Found

No
The provided text does not mention AI, ML, or any related concepts like image processing, deep learning, or neural networks. The intended use is for a standard bite registration process, which typically involves physical or digital impressions without AI/ML components.

No
The device is indicated for bite registration, which is a diagnostic or procedural aid rather than a direct treatment for a disease or condition. Therefore, it is not a therapeutic device.

No
The device is indicated for bite registration, which is a procedural step rather than a step involved in diagnosing a condition.

Unknown

The provided 510(k) summary is incomplete and lacks a device description, making it impossible to determine if the device is software-only.

Based on the provided information, it is highly unlikely that MEMOREG is an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use is "bite registration in all standard situations with a stable occlusion." This describes a process performed directly on a patient's mouth to record the relationship between their upper and lower teeth. This is a clinical procedure, not a diagnostic test performed on a sample taken from the body.
  • Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Detecting or measuring substances in a sample
    • Providing information about a disease or condition based on sample analysis

In summary, MEMOREG appears to be a dental device used for a clinical procedure (bite registration) and does not fit the definition of an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

MEMOREG is indicated for bite registration in all standard situations with a stable occlusion.

Product codes

ELW

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3660 Impression material.

(a)
Identification. Impression material is a device composed of materials such as alginate or polysulfide intended to be placed on a preformed impression tray and used to reproduce the structure of a patient's teeth and gums. The device is intended to provide models for study and for production of restorative prosthetic devices, such as gold inlays and dentures.(b)
Classification. Class II (Special Controls).

0

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image shows a logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with its wings spread, along with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the eagle. The image is in black and white and appears to be a scan or photocopy.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 2 2 1997

Ms. Cheryl V. Zimmerman Heraeus Kulzer, Incorporated 4315 south Lafayette Boulevard South Bend, Indiana 46614-2517

K971155 Re : Memoreg Bite Registration Material Trade Name: Regulatory Class: II Product Code: ELW Dated: March 21, 1997 March 28, 1997 Received:

Dear Ms. Zimmerman:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) requiation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

1

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire speeifie advice for your device on our labeling ---requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours

Timothy A. Ulatowski

Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Pre-Market Notification - MEMOREGT - - -

STATEMENT OF INDICATIONS FOR USE

MEMOREG is indicated for bite registration in all standard situations with a stable occlusion.

SummRums
Division Sign-Off)

ision of Dental, Infection Control, General Hospital Devices

Number 2471153